Saeed Madiha, Iqbal M Zubair, Ren Wenzhi, Xia Yuanzhi, Liu Chuang, Khan Waheed S, Wu Aiguo
CAS Key Laboratory of Magnetic Materials and Devices, & Key Laboratory of Additive Manufacturing Materials of Zhejiang Province, & Division of Functional Materials and Nanodevices, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, P. R. China.
J Mater Chem B. 2018 Jun 14;6(22):3800-3810. doi: 10.1039/c8tb00745d. Epub 2018 May 29.
Photothermal therapy (PTT) has emerged as one of the promising cancer therapy approaches. However, nanoparticles (NPs) which are used for PTT might be biopersistent and potentially toxic. The current research explores the promising use of FeO nanoflowers as nontoxic, efficient photothermal, and strong T type magnetic resonance imaging (MRI) contrast agents for imaging-guided photothermal cancer therapy. In this study, a facile solvothermal method is used to fabricate PEG-coated FeO nanoflowers with controllable dimensions. Their successful fabrication, the effect of the reaction parameters, and their magnetic properties are investigated in depth. The therapeutic performance of the FeO nanoflowers (Fe-NFs) is evaluated and compared with commercially available black TiO nanoparticles (b-TiO) under an 808 nm laser. The photothermal therapy efficiency of the Fe-NFs is observed to be better than that of the reported FeO nanoparticles. In vitro and in vivo investigation demonstrates that the therapeutic performance of the Fe-NFs is comparable to that of b-TiO. Moreover, the Fe-NFs show excellent magnetic properties and magnetic resonance imaging capability to monitor therapeutic performance.
光热疗法(PTT)已成为一种很有前景的癌症治疗方法。然而,用于光热疗法的纳米颗粒(NPs)可能具有生物持久性且有潜在毒性。当前研究探索了FeO纳米花作为无毒、高效光热且强T型磁共振成像(MRI)造影剂用于成像引导光热癌症治疗的潜在用途。在本研究中,采用一种简便的溶剂热法制备尺寸可控的聚乙二醇(PEG)包覆的FeO纳米花。对其成功制备、反应参数的影响及其磁性进行了深入研究。在808 nm激光下评估了FeO纳米花(Fe-NFs)的治疗性能,并与市售黑色TiO纳米颗粒(b-TiO)进行了比较。观察到Fe-NFs的光热治疗效率优于已报道的FeO纳米颗粒。体外和体内研究表明,Fe-NFs的治疗性能与b-TiO相当。此外,Fe-NFs表现出优异的磁性和磁共振成像能力以监测治疗效果。
ACS Biomater Sci Eng. 2019-2-11
Yao Xue Xue Bao. 2013-12
ACS Appl Mater Interfaces. 2017-5-23
Int J Nanomedicine. 2022
Mater Sci Eng C Mater Biol Appl. 2019-10-16
Chem Soc Rev. 2019-4-1